ENTITY

Beijing Luzhu Biotechnology (1868402D CH)

Analysis

Health Care • China

Beijing Luzhu Biotechnology Co., Ltd. operates pharmaceutical development businesses. The Company develops human monoclonal antibodies, bispecific antibody drugs, recombinant viral vaccines, and other products. Beijing Luzhu Biotechnology conducts businesses in China.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00